ArticleInsights into imaging2025
Habitat imaging combined with multimodal analysis for preoperative risk stratification of papillary thyroid carcinoma.
Article in Insights into imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Habitat imaging based on enhanced CT for predicting occult central lymph node metastasis in papillary thyroid carcinoma.European radiology · 2026Article
- Heterogeneity Analyzed by CT-Based Habitat Analysis for Clinical Management of Cancers: A Narrative Review.The Kaohsiung journal of medical sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectiveTo develop a comprehensive preoperative risk stratification model using habitat imaging combined with multimodal analysis for identifying low-risk papillary thyroid carcinoma (PTC) patients suitable for active surveillance. MATERIALS AND
methodsThis multicenter study analyzed 1215 patients with pathologically confirmed PTC from four Chinese institutions. Habitat imaging analysis was performed on preoperative CT and ultrasound images using K-means clustering and supervoxel segmentation. Radiomic features were extracted from ultrasound habitats using PyRadiomics, while multi-scale index (MSI) features were extracted from CT habitats. Clinical characteristics and immunological markers were identified through multivariate logistic regression. Six machine learning algorithms were evaluated with three fusion strategies to integrate imaging features with clinical data.
resultsFour ultrasound habitats and five CT habitats were identified. Ultrasound Habitat 2 achieved an AUC of 0.92 in training and 0.80-0.92 in validation. CT habitat analysis using MSI features achieved an AUC of 0.93 in training and 0.88-0.92 in validation. The optimal ensemble fusion model integrating CT-derived MSI features, ultrasound habitat characteristics, clinical parameters (chronic lymphocytic thyroiditis and tumor size) and immunological markers (platelet-to-lymphocyte ratio) achieved an AUC of 0.98 in training, 0.95 in internal validation, and 0.95-0.99 across external validation cohorts, with accuracy exceeding 0.88 in all validation sets.
conclusionHabitat imaging combined with multimodal analysis provides superior preoperative risk stratification for PTC, enabling personalized treatment planning and identification of low-risk patients suitable for active surveillance while potentially reducing unnecessary surgical interventions. CRITICAL RELEVANCE STATEMENT: Habitat imaging combined with multimodal analysis provides superior preoperative risk stratification for papillary thyroid carcinoma, enabling personalized treatment decisions and reducing unnecessary surgical interventions. KEY POINTS: Current papillary thyroid carcinoma (PTC) risk stratification relies on postoperative pathology, limiting preoperative treatment planning. Multimodal habitat imaging achieved exceptional performance across validation cohorts. This framework enables personalized treatment planning and identifies low-risk patients for active surveillance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.